Matches in Wikidata for { <http://www.wikidata.org/entity/Q37643232> ?p ?o ?g. }
- Q37643232 description "article científic" @default.
- Q37643232 description "article scientifique" @default.
- Q37643232 description "articolo scientifico" @default.
- Q37643232 description "artigo científico" @default.
- Q37643232 description "artículu científicu espublizáu en 2017" @default.
- Q37643232 description "bilimsel makale" @default.
- Q37643232 description "bài báo khoa học" @default.
- Q37643232 description "scientific article published on February 2017" @default.
- Q37643232 description "vedecký článok" @default.
- Q37643232 description "vetenskaplig artikel" @default.
- Q37643232 description "videnskabelig artikel" @default.
- Q37643232 description "vědecký článek" @default.
- Q37643232 description "wetenschappelijk artikel" @default.
- Q37643232 description "wissenschaftlicher Artikel" @default.
- Q37643232 description "наукова стаття, опублікована в лютому 2017" @default.
- Q37643232 description "научни чланак" @default.
- Q37643232 description "مقالة علمية نشرت في فبراير 2017" @default.
- Q37643232 name "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 name "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 name "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 type Item @default.
- Q37643232 label "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 label "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 label "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 prefLabel "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 prefLabel "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 prefLabel "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy." @default.
- Q37643232 P1433 Q37643232-98D242D2-1955-42AB-884B-32375AE77098 @default.
- Q37643232 P1476 Q37643232-007B7D55-237B-4BEA-B52F-D85D42C17523 @default.
- Q37643232 P2093 Q37643232-1EA44A6C-4EA4-4298-B637-5AF972467A5A @default.
- Q37643232 P2093 Q37643232-34B6BC61-02D6-4F52-B84B-8E4794ADBE03 @default.
- Q37643232 P2093 Q37643232-572E7B5F-8671-4E70-9DB8-F2A5D0432BF7 @default.
- Q37643232 P2093 Q37643232-83C7AAF9-99C3-479B-AAE2-712DA1D0A728 @default.
- Q37643232 P2093 Q37643232-8C639F77-1078-4B8F-916D-E78A8F0863FB @default.
- Q37643232 P2093 Q37643232-91C34013-0285-42EA-BC99-91B861C9540D @default.
- Q37643232 P2093 Q37643232-A9EDCD16-7108-4D18-8A2E-B2C802FA95B6 @default.
- Q37643232 P2093 Q37643232-E96640B5-C686-4EBA-A81E-FA808F4FB6C1 @default.
- Q37643232 P2093 Q37643232-EF7EA90A-AE7D-46E5-A702-1902C64E79E4 @default.
- Q37643232 P2860 Q37643232-035F64A0-D2FB-4127-AEA7-A78E2D5A4BDE @default.
- Q37643232 P2860 Q37643232-0508AC96-4DB6-42C8-A7BC-15F53C1752F7 @default.
- Q37643232 P2860 Q37643232-276152F4-6919-41F2-95B0-AAF04079B3D2 @default.
- Q37643232 P2860 Q37643232-29ABD21B-B735-4D03-942D-18E3EB6B8B02 @default.
- Q37643232 P2860 Q37643232-3043974D-8B6B-40C9-9E87-F71121C5FBC4 @default.
- Q37643232 P2860 Q37643232-31BF4CE7-05B2-4F2D-8058-168B39AE48E4 @default.
- Q37643232 P2860 Q37643232-4280DC16-1C35-43EE-B800-CEA19E395E67 @default.
- Q37643232 P2860 Q37643232-455A8D6C-869A-4DF8-83A7-5C34B4726579 @default.
- Q37643232 P2860 Q37643232-5D2ED83B-47C8-45B8-993A-FA929FC33E95 @default.
- Q37643232 P2860 Q37643232-652452A4-8E45-4641-B602-5CBD8EE5A95E @default.
- Q37643232 P2860 Q37643232-7190084E-8FC4-4F6A-ADBC-9A853C650B6E @default.
- Q37643232 P2860 Q37643232-787698DC-E949-4381-9EFD-99C324C106E7 @default.
- Q37643232 P2860 Q37643232-8A61A852-1BA7-4B32-BF9D-79B33179D585 @default.
- Q37643232 P2860 Q37643232-90161B6B-1866-40E4-839F-B1AFD1A65268 @default.
- Q37643232 P2860 Q37643232-98EC5684-2AB5-485D-A9F4-D3619520D1F5 @default.
- Q37643232 P2860 Q37643232-AC9F1312-739C-48DD-9C5C-49937D320BDA @default.
- Q37643232 P2860 Q37643232-AD9F890B-3694-4792-982A-28A19C5A521A @default.
- Q37643232 P2860 Q37643232-B6785A8A-51B6-4866-B916-D5E3B70BFDAF @default.
- Q37643232 P2860 Q37643232-C2284D8E-ECC5-40BF-8F2F-FC32CE02DBA1 @default.
- Q37643232 P2860 Q37643232-D3E78B6B-0B19-47B0-A387-69FA48BCBDE7 @default.
- Q37643232 P2860 Q37643232-DBF9DBE8-7491-4D57-AFB3-D4F857D7EE57 @default.
- Q37643232 P2860 Q37643232-E0B9A31F-333A-41E1-8303-884C7B8E78E5 @default.
- Q37643232 P2860 Q37643232-EB375E6F-EDDF-4F0F-9CF0-3B3DE8E790CE @default.
- Q37643232 P304 Q37643232-C7C80697-A058-4908-BC5D-E5EF0EE32E3E @default.
- Q37643232 P31 Q37643232-6D0EF46B-7A4B-4D74-8097-A2D414C3B010 @default.
- Q37643232 P356 Q37643232-9186EB2D-888B-427E-8EBE-8BA3B1B39AD8 @default.
- Q37643232 P433 Q37643232-F47C7D69-92E2-4703-A167-FB4216E3DB45 @default.
- Q37643232 P478 Q37643232-A87FBA08-28FA-49A9-BAF0-2B411AB58846 @default.
- Q37643232 P50 Q37643232-17F68511-43BE-478F-84FF-B622BAF003D0 @default.
- Q37643232 P50 Q37643232-EAD067A7-776C-4B3D-9E4F-3664423BA727 @default.
- Q37643232 P577 Q37643232-A03FE510-CCFE-4F89-A4F5-C80FF584B12D @default.
- Q37643232 P698 Q37643232-0E8CDA8E-5321-462D-9C77-20D6E2FEFFAB @default.
- Q37643232 P921 Q37643232-9219806A-53EB-4E73-9346-C7CB3744235C @default.
- Q37643232 P921 Q37643232-D1AA5F73-0469-4684-B1D8-7977AC73B45C @default.
- Q37643232 P921 Q37643232-FC53231F-B286-4D42-A267-DEEADFCEF23C @default.
- Q37643232 P932 Q37643232-823975F3-A0CF-4FAF-A4D7-2B3C11F00E79 @default.
- Q37643232 P356 CPJ.0000000000000316 @default.
- Q37643232 P698 28243505 @default.
- Q37643232 P1433 Q26853885 @default.
- Q37643232 P1476 "Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy" @default.
- Q37643232 P2093 "Alberto J Espay" @default.
- Q37643232 P2093 "Cheryl H Waters" @default.
- Q37643232 P2093 "Dee E Silver" @default.
- Q37643232 P2093 "Fernando L Pagan" @default.
- Q37643232 P2093 "John C Morgan" @default.
- Q37643232 P2093 "Kevin J Klos" @default.
- Q37643232 P2093 "Lawrence W Elmer" @default.
- Q37643232 P2093 "Pinky Agarwal" @default.
- Q37643232 P2093 "William G Ondo" @default.
- Q37643232 P2860 Q34273182 @default.
- Q37643232 P2860 Q34554465 @default.
- Q37643232 P2860 Q36445093 @default.
- Q37643232 P2860 Q36542313 @default.
- Q37643232 P2860 Q36818368 @default.
- Q37643232 P2860 Q37054013 @default.
- Q37643232 P2860 Q37808677 @default.
- Q37643232 P2860 Q38261811 @default.
- Q37643232 P2860 Q38275513 @default.
- Q37643232 P2860 Q38726345 @default.
- Q37643232 P2860 Q39673262 @default.
- Q37643232 P2860 Q40725534 @default.
- Q37643232 P2860 Q42609024 @default.